Top Healthcare Companies by Net Margin
Trailing-twelve-month net margin for the largest Healthcare filers, ranked in USD. Switch axes via the column headers.
How TTM margins are measured
Margins divide a profitability line by trailing-twelve-month revenue, expressed as a percentage. Each column on this page measures a different layer of the income statement — gross strips only direct production costs; operating subtracts overhead, R&D and D&A; EBITDA adds D&A back to operating; net subtracts interest and taxes; FCF replaces accrual profit with operating cash flow minus capex. Together they describe where a business actually makes its money.
Margins make capital-light franchises directly comparable to capital-heavy ones — a software filer with a 35% operating margin runs a different model than a global retailer at 6%. To compare absolute scale instead of percentages see the revenue ranking and net income ranking. Non-USD filers are ranked on USD-translated TTM lines so peers stay comparable. Rankings USD translation methodology · IFRS IAS 21 (official)
Calculated from each company's four most recent reported quarters, as of (reported ).
Sector scopeHealthcareChange sectorChange sector
Top healthcare companies by net margin
Click a column header to re-order rows. Company names link to each ticker's profile page.
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | Novo Nordisk (NVO) | Healthcare | 80.9% | 41.1% | 51.0% | 33.0% | 9.2% |
| 2 | Vertex Pharmaceuticals (VRTX) | Healthcare | 86.3% | 35.5% | 40.1% | 32.8% | 26.5% |
| 3 | Eli Lilly (LLY) | Healthcare | 83.8% | 45.6% | 42.9% | 31.7% | 13.8% |
| 4 | Regeneron Pharmaceuticals (REGN) | Healthcare | 85.4% | 24.9% | 40.6% | 31.4% | 28.4% |
| 5 | Gilead Sciences (GILD) | Healthcare | 80.8% | 37.4% | 43.8% | 28.9% | 32.1% |
| 6 | Zoetis (ZTS) | Healthcare | 70.5% | 38.0% | 43.2% | 28.2% | 24.1% |
| 7 | Intuitive Surgical (ISRG) | Healthcare | 66.3% | 30.5% | 35.5% | 28.2% | 26.8% |
| 8 | Merck & Co. (MRK) | Healthcare | 81.5% | 41.2% | 40.5% | 28.1% | 19.0% |
| 9 | ResMed (RMD) | Healthcare | 61.0% | 33.8% | 38.4% | 27.5% | 33.1% |
| 10 | Incyte (INCY) | Healthcare | 70.1% | 26.8% | 33.7% | 26.7% | 27.1% |
| 11 | IDEXX Laboratories (IDXX) | Healthcare | 61.8% | 31.6% | 35.1% | 24.6% | 24.5% |
| 12 | Mettler Toledo (MTD) | Healthcare | 57.5% | 27.8% | 30.8% | 21.6% | 21.1% |
| 13 | Johnson & Johnson (JNJ) | Healthcare | 70.0% | 26.4% | 30.3% | 21.4% | 18.4% |
| 14 | Amgen (AMGN) | Healthcare | 70.5% | 28.0% | 50.8% | 21.0% | 22.0% |
| 15 | Waters Corporation (WAT) | Healthcare | 58.9% | 26.6% | 32.4% | 20.3% | 17.1% |
| 16 | Illumina (ILMN) | Healthcare | 66.5% | 19.9% | 33.6% | 19.6% | 21.6% |
| 17 | Solventum (SOLV) | Healthcare | 53.5% | 26.2% | 33.8% | 18.7% | -0.1% |
| 18 | Agilent Technologies (A) | Healthcare | 52.2% | 20.6% | 25.8% | 18.3% | 14.1% |
| 19 | DexCom (DXCM) | Healthcare | 60.1% | 19.6% | 28.7% | 17.9% | 23.1% |
| 20 | AstraZeneca (AZN) | Healthcare | 81.9% | 23.4% | 33.8% | 17.4% | 18.0% |
| 21 | Edwards Lifesciences (EW) | Healthcare | 78.0% | 27.6% | 22.8% | 17.3% | 21.2% |
| 22 | Boston Scientific (BSX) | Healthcare | 70.4% | 20.1% | 23.1% | 17.2% | 17.6% |
| 23 | West Pharmaceutical Services (WST) | Healthcare | 36.2% | 20.7% | 24.8% | 16.9% | 14.2% |
| 24 | Thermo Fisher Scientific (TMO) | Healthcare | 39.4% | 17.8% | 24.7% | 15.2% | 14.9% |
| 25 | Danaher (DHR) | Healthcare | 60.7% | 21.0% | 27.0% | 14.9% | 21.4% |
| 26 | Bristol-Myers Squibb (BMY) | Healthcare | 67.6% | 26.3% | 30.2% | 14.6% | 26.7% |
| 27 | Abbott Laboratories (ABT) | Healthcare | 56.4% | 18.2% | 23.9% | 13.9% | 16.4% |
| 28 | Biogen (BIIB) | Healthcare | 70.5% | 19.1% | 31.6% | 13.2% | 21.8% |
| 29 | Medtronic (MDT) | Healthcare | 61.9% | 17.9% | 26.4% | 13.0% | 15.2% |
| 30 | Stryker (SYK) | Healthcare | 63.5% | 22.4% | 22.2% | 12.9% | 17.1% |
| 31 | Pfizer (PFE) | Healthcare | 70.3% | 24.7% | 26.8% | 12.4% | 14.5% |
| 32 | STERIS (STE) | Healthcare | 44.1% | 17.2% | 23.4% | 12.1% | 15.7% |
| 33 | AptarGroup (ATR) | Healthcare | 29.6% | 13.5% | 22.0% | 10.4% | 7.8% |
| 34 | Align Technology (ALGN) | Healthcare | 67.3% | 13.6% | 20.0% | 10.2% | 14.7% |
| 35 | Cooper Companies (COO) | Healthcare | 64.2% | 17.2% | 23.2% | 9.7% | 11.8% |
| 36 | Insulet (PODD) | Healthcare | 71.6% | 17.5% | 18.0% | 9.1% | 13.9% |
| 37 | Quest Diagnostics (DGX) | Healthcare | 33.2% | 14.3% | 17.6% | 9.1% | 11.8% |
| 38 | HCA Healthcare (HCA) | Healthcare | 34.9% | 15.7% | 20.5% | 8.9% | 10.4% |
| 39 | Universal Health Services (UHS) | Healthcare | 90.4% | 11.5% | 15.8% | 8.6% | 4.8% |
| 40 | GE HealthCare (GEHC) | Healthcare | 43.5% | 13.3% | 18.3% | 8.6% | 7.7% |
| 41 | Zimmer Biomet Holdings (ZBH) | Healthcare | 69.7% | 15.0% | 26.9% | 8.6% | 22.5% |
| 42 | Revvity (RVTY) | Healthcare | 50.2% | 13.0% | 26.8% | 8.5% | 17.9% |
| 43 | Alnylam Pharmaceuticals (ALNY) | Healthcare | 81.7% | 13.5% | 12.7% | 8.4% | 12.5% |
| 44 | IQVIA (IQV) | Healthcare | 26.3% | 14.0% | 21.2% | 8.3% | 15.2% |
| 45 | Becton, Dickinson and (BDX) | Healthcare | 45.8% | 12.4% | 23.2% | 8.0% | 12.0% |
| 46 | AbbVie (ABBV) | Healthcare | 70.2% | 26.7% | 28.8% | 6.9% | 30.6% |
| 47 | Bio-Techne (TECH) | Healthcare | 65.2% | 9.6% | 18.7% | 6.7% | 18.3% |
| 48 | Labcorp Holdings (LH) | Healthcare | 28.2% | 10.7% | 14.4% | 6.3% | 8.6% |
| 49 | DaVita (DVA) | Healthcare | 30.9% | 14.9% | 19.4% | 5.5% | 9.6% |
| 50 | Henry Schein (HSIC) | Healthcare | 29.1% | 5.8% | 7.6% | 3.0% | 4.3% |
| 51 | UnitedHealth Group (UNH) | Healthcare | 18.8% | 4.2% | 5.1% | 2.7% | 4.4% |
| 52 | Elevance Health (ELV) | Healthcare | 23.2% | 3.8% | 4.4% | 2.6% | 3.2% |
| 53 | Cigna (CI) | Healthcare | 9.5% | 3.3% | 4.4% | 2.2% | 3.1% |
| 54 | McKesson (MCK) | Healthcare | 3.4% | 1.3% | 1.6% | 1.1% | 2.5% |
| 55 | Humana (HUM) | Healthcare | 14.5% | 1.1% | 2.2% | 0.9% | 0.3% |
| 56 | Cardinal Health (CAH) | Healthcare | 3.6% | 1.0% | 1.3% | 0.7% | 2.3% |
| 57 | Cencora (COR) | Healthcare | 3.3% | 1.2% | 1.2% | 0.5% | 1.1% |
| 58 | CVS Health (CVS) | Healthcare | 13.8% | 1.2% | 2.5% | 0.4% | 1.9% |
| 59 | Molina Healthcare (MOH) | Healthcare | 9.6% | 1.2% | 1.4% | 0.4% | 0.6% |
| 60 | Centene (CNC) | Healthcare | 14.9% | -3.7% | -2.6% | -3.3% | 3.2% |
| 61 | Charles River (CRL) | Healthcare | 32.9% | 10.7% | 20.0% | -3.6% | 12.9% |
| 62 | Baxter International (BAX) | Healthcare | 30.1% | -2.7% | 6.8% | -8.5% | 2.9% |
| 63 | Viatris (VTRS) | Healthcare | 35.1% | -18.6% | -2.8% | -24.6% | 12.7% |
| 64 | Moderna (MRNA) | Healthcare | 14.1% | -158.2% | -131.3% | -145.2% | -105.7% |
Sorted by Net Margin · Ranks (#) are among the loaded leaderboard rows, not worldwide.